Acyclovir description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Acyclovir

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

ACYCLOVIR DESCRIPTION








Acyclovir




VIROLOGY





CLINICAL PHARMACOLOGY
















CLINICAL PHARMACOLOGY

Initial Genital Herpes:
Recurrent Genital Herpes:
Herpes Zoster Infections:
Chickenpox:


INDICATIONS & USAGE

Herpes Zoster Infections:
Genital Herpes:
Chickenpox:

ACYCLOVIR CONTRAINDICATIONS




WARNINGS



PRECAUTIONS


Information for Patients:
Herpes Zoster:
Genital Herpes Infections:
Chickenpox:

DRUG INTERACTIONS




CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY






PREGNANCY




NURSING MOTHERS




PEDIATRIC USE




GERIATRIC USE




ACYCLOVIR ADVERSE REACTIONS

Herpes Simplex:
Long-Term Administration:
Herpes Zoster:
Chickenpox:Observed During Clinical Practice:

General:
Nervous:
Digestive:
Hematologic and Lymphatic:
Hepatobiliary Tract and Pancreas:

Skin:
Special Senses:
Urogenital:


OVERDOSAGE



DOSAGE & ADMINISTRATION

Acute Treatment of Herpes Zoster:
Genital Herpes:
Chronic Suppressive Therapy for Recurrent Disease:
Intermittent Therapy:
Treatment of Chickenpox:
Adults and Children over 40 kg:


Hemodialysis:
Peritoneal Dialysis:
Bioequivalence of Dosage Forms:

HOW SUPPLIED




PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Acyclovir



Acyclovir



PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
















PACKAGE LABEL.PRINCIPAL DISPLAY PANEL













Acyclovir

Acyclovir CAPSULE

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-377(NDC:61442-111)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
ACYCLOVIR ACYCLOVIR 200 mg

Inactive Ingredients

Ingredient Name Strength
lactose monohydrate
SODIUM STARCH GLYCOLATE TYPE A POTATO
SODIUM LAURYL SULFATE
MAGNESIUM STEARATE

Product Characteristics

Color Size Imprint Code Shape
white 10 mm 200;CTI;111 OVAL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-377-02 30 in 1 BLISTER PACK
2 NDC:49349-377-20 100 in 1 CANISTER
3 NDC:49349-377-03 20 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA075382 2011-07-14


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.